Kodiak Sciences Statistics
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
97.17-0.73 (-0.75%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Kodiak Sciences by the numbers
Kodiak Sciences has a market capitalization of $6.35 billion based on 65.40M shares outstanding. With trailing EPS of $-4.08, Kodiak Sciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.9% above its 50-day average and 103.3% above its 200-day average.
Average daily trading volume is 1.77M shares, or about $171.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KOD valuation vs. peer median
| Metric | KOD | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.35B | $6.49B | -2% |
| Avg. volume | 1.77M | 2.02M | -13% |
Peer median across 8 companies: IBRX, IMVT, SRRK, TWST, CGON, ADPT, PCVX, CRSP.
Valuation
- Market cap
- $6.35B
- EPS (TTM)
- $-4.08
- Shares outstanding
- 65.40M
Price and trading
- Previous close
- 97.90
- Open
- 97.39
- Day range
- 96.53 – 100.89
- 52-week range
- 20.38 – 112.79
- 52-week change
- +367.84%
- Beta
- —
- Volume
- 692.96K
- Average volume
- 1.77M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 6.35B
- Forward Pe
- -27.79
- Eps
- -4.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 112.79
- Week52 Low
- 20.38
- Avg Volume
- 1.77M
- Shares Outstanding
- 65.40M
- Ma50
- 83.13
- Ma200
- 47.81
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -13.85%
- Pct From52w Low
- 376.79%